Type 2 Diabetes - To Prevent Dementia Diabetic Women Need Estrogen Levels Checked Before Menopause
Alzheimer's is the most common form of dementia and is on the rise.
But women who have both Type 2 diabetes and high estrogen levels, are at a significantly higher risk of developing dementia according to new research published in the journal Neurology.
Older Women with Type 2 Diabetes at High Risk of Developing Dementia.
This research has suggested women who were aged 65 or older were...
During the study all women were assessed for risk factors for dementia, including...
As well as an increased risk for developing dementia, if the women in the study had diabetes and high estrogen levels, the research team also found women with both dementia and diabetes had estrogen levels 70% higher than women who only had diabetes.
The team did not find the dementia risk increased with any other heart health risk factors.
Researchers Stunned by Results of New Study.
Studies carried out previously had suggested undergoing estrogen-based therapies may have a protective effect on the brain, which is why Dr.
Scarabin, the study author, said the team and himself were very surprised by the findings, going on to say...
"However, more and more evidence suggests an association between high estradiol levels and dementia in women who have undergone menopause.
Considering the expected increase in the number of elderly people with diabetes and dementia, more research on this topic should be urgently conducted.
" Timing of Therapy May Make all the Difference.
In 2012 Johns Hopkins University in Baltimore, MD, carried out a study that suggested hormone therapy may affect women's risk of developing Alzheimer's disease but the risk actually depended on the timing of the therapy.
Through this study it was concluded women who underwent hormone therapy before menopause were believed to have a lower risk of developing Alzheimer's disease.
But if you were to start this therapy after menopause, this may lead to an increased risk.
Women with Diabetes Should Receive Mandatory Hormone Testing.
Currently it is known having Type 2 diabetes is a risk factor for going on to developing dementia and this is why it should become mandatory to screen women's hormones levels well before they reach menopause, especially in light of the emerging scientific evidence.
This might make all the difference to a person who is already struggling to manage the complicated disease that is Type 2 diabetes and them going on to develop dementia, which is another problematic disease requiring a lot of help to manage.
But women who have both Type 2 diabetes and high estrogen levels, are at a significantly higher risk of developing dementia according to new research published in the journal Neurology.
Older Women with Type 2 Diabetes at High Risk of Developing Dementia.
This research has suggested women who were aged 65 or older were...
- 14 times more likely to develop dementia if they had diabetes and high estrogen levels.
- high estrogen levels but not diabetes who were twice as likely to develop dementia when they were then compared to women diabetes free and low estrogen levels.
During the study all women were assessed for risk factors for dementia, including...
- Type 2 diabetes,
- high blood pressure, and
- abnormal blood clotting,
As well as an increased risk for developing dementia, if the women in the study had diabetes and high estrogen levels, the research team also found women with both dementia and diabetes had estrogen levels 70% higher than women who only had diabetes.
The team did not find the dementia risk increased with any other heart health risk factors.
Researchers Stunned by Results of New Study.
Studies carried out previously had suggested undergoing estrogen-based therapies may have a protective effect on the brain, which is why Dr.
Scarabin, the study author, said the team and himself were very surprised by the findings, going on to say...
"However, more and more evidence suggests an association between high estradiol levels and dementia in women who have undergone menopause.
Considering the expected increase in the number of elderly people with diabetes and dementia, more research on this topic should be urgently conducted.
" Timing of Therapy May Make all the Difference.
In 2012 Johns Hopkins University in Baltimore, MD, carried out a study that suggested hormone therapy may affect women's risk of developing Alzheimer's disease but the risk actually depended on the timing of the therapy.
Through this study it was concluded women who underwent hormone therapy before menopause were believed to have a lower risk of developing Alzheimer's disease.
But if you were to start this therapy after menopause, this may lead to an increased risk.
Women with Diabetes Should Receive Mandatory Hormone Testing.
Currently it is known having Type 2 diabetes is a risk factor for going on to developing dementia and this is why it should become mandatory to screen women's hormones levels well before they reach menopause, especially in light of the emerging scientific evidence.
This might make all the difference to a person who is already struggling to manage the complicated disease that is Type 2 diabetes and them going on to develop dementia, which is another problematic disease requiring a lot of help to manage.
